Medical Psilocybin Legalization: What it Means for Workplace Drug Testing
As more states begin legalizing medical psilocybin, the hallucinogenic found in “magic mushrooms,” employers are facing new challenges in maintaining compliant and effective drug testing programs. While psilocybin remains a Schedule I substance under federal law, state-level changes are creating uncertainty for companies, especially those operating across multiple states or in safety-sensitive industries.
Where is medical psilocybin legal?
As of August 2025, three states have legalized medical psilocybin:
- Oregon, via a ballot initiative
- Colorado, via a ballot initiative
- New Mexico, which passed the Medical Psilocybin Act in June 2025.
Each state has its own framework for licensing, prescribing, and administering psilocybin.
What about safety-sensitive roles?
Since psilocybin is still classified as a Schedule I substance under federal law, employees who are subject to federal regulations, such as those under the Department of Transportation (DOT), cannot possess or consume psilocybin, regardless of prescription status.
What challenges does this pose for employers?
Detection Limitations
Unlike other Schedule I substances, psilocybin typically isn’t included on standard employment drug panels. In addition, psilocybin metabolizes much more quickly than substances such as THC or amphetamines, making it more difficult to identify recent use, particularly in post-accident or reasonable suspicion scenarios.
Policy Confusion
It’s imperative for employers to understand that state-level protections do not override federal law. This should be a particular concern for companies with operations in multiple states, or those managing safety-sensitive fields such as the Department of Transportation (DOT).
Know the regulation for safety-sensitive roles.
Even if an employee is legally prescribed psilocybin, its psychoactive effects can pose serious risks in roles involving driving, machinery, or public safety. For this reason, employees under federal regulations, such as the Department of Transportation (DOT), may still face disciplinary action if they test positive for psilocybin, even with a valid medical prescription (much like medical marijuana).
TEAM’s Recommendation for Employers
Our experts recommend the following steps to navigate the evolving landscape of medical psilocybin legalization:
- Review and update your existing drug testing policies to explicitly address Schedule I substances, including psilocybin.
- Train your supervisors on reasonable suspicion protocols and documentation.
- Consult legal counsel when operating in states with medical psilocybin laws to ensure compliance and reduce liability.
- Maintain consistency across jurisdictions to avoid discrimination claims and ensure workplace safety.
As these regulations continue to evolve, employers need to stay ahead of the curve. By proactively reviewing policies, training your teams, and seeking expert guidance, organizations can protect their workforce and maintain compliance, no matter how the legal landscape shifts.
For additional help navigating these changes with clarity and confidence, reach out to our TEAM to review your current policies or schedule a compliance consultation.
